Netherlands· NL-c6dcb455691d

Synapause-E3 2 mg, tabletten

A estriol product containing estriol, registered in Netherlands by Aspen Pharma Trading Limited. The same ATC class is registered in 13 of our 19 countries.

ATC G03CA04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about estriolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Estriol is registered in 13 of 19 countries.

Countries holding a registration under ATC G03CA04 (estriol), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search estriol products by name

Estriol · ATC G03CA04

13 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of estriol costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Estriol · price per daily dose (2 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.07

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ESTRIOL
Manufacturer: Aspen Pharma Trading Limited
Country: Netherlands (NL)
ATC code: G03CA04
ATC class: Estriol
Defined daily dose: 2 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
09970

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for estriol.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check estriol against other medicines How interaction checks work

Estriol · interactions on record

10 records

10 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Estriol in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All estriol products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Blissel, Estrokad
Belgium · Aacifemine, Blissel
Cyprus · Blissel
Czechia · Estriol Wolff, Ovestin
Germany · Estriol Wolff, Oekolp
Denmark · Estrokad, Gelisse
Estonia · Ovestin
Spain · Blissel, Femmyn
Finland · Blissel, Estrokad
France · Blissel, Gydrelle
United Kingdom (Northern Ireland) · Blissel, Estriol Aspen Pharma
Greece · Blissel, Gelistrol
Croatia · Vaginelle
Hungary · Estriol Wolff, Estrokad
Ireland · Blissel, Imvaggis
Iceland · Ovestin
Italy · Atrocom, Colpogyn
Lithuania · Ovestin
Luxembourg · Aacifemine, Oekolp
Latvia · Ovestin
Malta · Ovestin
Norway · Gelisse, Ovesterin
Poland · Blissel, Oekolp
Portugal · Blissel, Gelistrol
Romania · Ovestin
Sweden · Blissel, Estrokad
Slovakia · Estriol Wolff, Ovestin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/10aa50b6-a2d9-42ae-84da-853dad4d9643
GET /v1/drugs/10aa50b6-a2d9-42ae-84da-853dad4d9643?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h09970_smpc.pdf",
  "strength": null,
  "atc_label": "Estriol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg09970",
  "excipients": [
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POTATO STARCH (RI)",
    "POVIDON (E 1201)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "ESTRIOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h09970.pdf",
  "authorised_at": "1982/12/21",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "09970",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about estriol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console